A modified CD9 tag for efficient protein delivery via extracellular vesicles
Extracellular vesicles (EVs) are attracting growing attention for therapeutic use and as diagnostic markers, particularly for cancer. Although therapies based on small interfering RNAs are under intensive research, other therapeutic molecules, especially proteins, have not been sufficiently investig...
Gespeichert in:
Veröffentlicht in: | PloS one 2024-10, Vol.19 (10), p.e0310083 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 10 |
container_start_page | e0310083 |
container_title | PloS one |
container_volume | 19 |
creator | Inano, Shojiro Kitano, Toshiyuki |
description | Extracellular vesicles (EVs) are attracting growing attention for therapeutic use and as diagnostic markers, particularly for cancer. Although therapies based on small interfering RNAs are under intensive research, other therapeutic molecules, especially proteins, have not been sufficiently investigated. One of the major method for loading proteins into EVs is electroporation; however, it damages membrane integrity and requires repeated purification, precluding clinical applications. Thus, natural and efficient protein transfer is a prerequisite for the clinical application of protein-based EV therapy. Another prerequisite is an efficient endosomal escape, as most EVs incorporated into receptor cells result in endosomal degradation. Therefore, we generated a short CD9 (sCD9)-INF/TAT tag for efficiently transfers fused proteins to the EV and enhances endosomal escape to address the abovementioned problems. Interestingly, protein transfer via EVs drastically improved when the EV producer and receptor cells were cocultured, strongly indicating bystander effects of cells producing therapeutic proteins fused with a sCD9-INF/TAT tag. This method can be applied to a wide range of therapeutic technologies, including cellular transplantation or viral therapy. |
doi_str_mv | 10.1371/journal.pone.0310083 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_3117920035</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A812597253</galeid><sourcerecordid>A812597253</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-82850cf28edc4b7a838506bcee6c0a047d77dd7228fb4cd91ffae95cc585b7033</originalsourceid><addsrcrecordid>eNqNkltr2zAYhsXYWLts_2BshsHYLpLpYFvy1QjZqRAo7HQrZPlToiJbqWSH9d9Ppm6JRy-GLnR63lf6Dgi9JHhFGCcfrvwQOuVWB9_BCjOCsWCP0DmpGF2WFLPHJ-sz9CzGK4wLJsryKTpjVU4E5fQcbddZ6xtrLDTZ5lOV9WqXGR8yMMZqC12fHYLvwXZZA84eIdxkR6sy-NMHpcG5wamQHSFa7SA-R0-MchFeTPMC_fry-efm23J7-fVis94udV7ifimoKLA2VECj85orwdK-rDVAqbHCOW84bxpOqTB1rpuKGKOgKrQuRFFzzNgCvb71PTgf5ZSIKBkhvKIYsyIRHydiqNv0TAokKCcPwbYq3EivrJzfdHYvd_4oCclFmbMyObybHIK_HiD2srVxjFh14IfpsYrlCV6gN_-gD39ponbKgbSd8WMKR1O5FoQWFafFGNrqASqNBlqrU6mNTeczwfuZIDF9qs5ODTHKix_f_5-9_D1n356we1Cu30fvht76Ls7B_BbUwccYwNxnmWA5dupdNuTYqXLq1CR7dVqhe9Fda7K_nEfjFA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3117920035</pqid></control><display><type>article</type><title>A modified CD9 tag for efficient protein delivery via extracellular vesicles</title><source>MEDLINE</source><source>Public Library of Science</source><source>Full-Text Journals in Chemistry (Open access)</source><source>DOAJ Directory of Open Access Journals</source><source>Free E-Journal (出版社公開部分のみ)</source><source>PubMed Central</source><creator>Inano, Shojiro ; Kitano, Toshiyuki</creator><contributor>Kim, Cheorl-Ho</contributor><creatorcontrib>Inano, Shojiro ; Kitano, Toshiyuki ; Kim, Cheorl-Ho</creatorcontrib><description>Extracellular vesicles (EVs) are attracting growing attention for therapeutic use and as diagnostic markers, particularly for cancer. Although therapies based on small interfering RNAs are under intensive research, other therapeutic molecules, especially proteins, have not been sufficiently investigated. One of the major method for loading proteins into EVs is electroporation; however, it damages membrane integrity and requires repeated purification, precluding clinical applications. Thus, natural and efficient protein transfer is a prerequisite for the clinical application of protein-based EV therapy. Another prerequisite is an efficient endosomal escape, as most EVs incorporated into receptor cells result in endosomal degradation. Therefore, we generated a short CD9 (sCD9)-INF/TAT tag for efficiently transfers fused proteins to the EV and enhances endosomal escape to address the abovementioned problems. Interestingly, protein transfer via EVs drastically improved when the EV producer and receptor cells were cocultured, strongly indicating bystander effects of cells producing therapeutic proteins fused with a sCD9-INF/TAT tag. This method can be applied to a wide range of therapeutic technologies, including cellular transplantation or viral therapy.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0310083</identifier><identifier>PMID: 39418272</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Antibodies ; Biology and Life Sciences ; CD9 antigen ; Chromatography ; Dosage and administration ; Electroporation ; Endosomes - metabolism ; Extracellular vesicles ; Extracellular Vesicles - metabolism ; Health aspects ; HEK293 Cells ; Humans ; Lipid membranes ; Physiological aspects ; Plasmids ; Protein purification ; Protein therapy ; Protein Transport ; Proteins ; Receptors ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - metabolism ; Research and Analysis Methods ; Tat protein ; Tetraspanin 29 - metabolism ; Therapeutic applications ; Vesicles</subject><ispartof>PloS one, 2024-10, Vol.19 (10), p.e0310083</ispartof><rights>Copyright: © 2024 Inano, Kitano. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2024 Public Library of Science</rights><rights>2024 Inano, Kitano. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 Inano, Kitano 2024 Inano, Kitano</rights><rights>2024 Inano, Kitano. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c460t-82850cf28edc4b7a838506bcee6c0a047d77dd7228fb4cd91ffae95cc585b7033</cites><orcidid>0000-0003-0210-1158</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486436/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486436/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39418272$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kim, Cheorl-Ho</contributor><creatorcontrib>Inano, Shojiro</creatorcontrib><creatorcontrib>Kitano, Toshiyuki</creatorcontrib><title>A modified CD9 tag for efficient protein delivery via extracellular vesicles</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Extracellular vesicles (EVs) are attracting growing attention for therapeutic use and as diagnostic markers, particularly for cancer. Although therapies based on small interfering RNAs are under intensive research, other therapeutic molecules, especially proteins, have not been sufficiently investigated. One of the major method for loading proteins into EVs is electroporation; however, it damages membrane integrity and requires repeated purification, precluding clinical applications. Thus, natural and efficient protein transfer is a prerequisite for the clinical application of protein-based EV therapy. Another prerequisite is an efficient endosomal escape, as most EVs incorporated into receptor cells result in endosomal degradation. Therefore, we generated a short CD9 (sCD9)-INF/TAT tag for efficiently transfers fused proteins to the EV and enhances endosomal escape to address the abovementioned problems. Interestingly, protein transfer via EVs drastically improved when the EV producer and receptor cells were cocultured, strongly indicating bystander effects of cells producing therapeutic proteins fused with a sCD9-INF/TAT tag. This method can be applied to a wide range of therapeutic technologies, including cellular transplantation or viral therapy.</description><subject>Antibodies</subject><subject>Biology and Life Sciences</subject><subject>CD9 antigen</subject><subject>Chromatography</subject><subject>Dosage and administration</subject><subject>Electroporation</subject><subject>Endosomes - metabolism</subject><subject>Extracellular vesicles</subject><subject>Extracellular Vesicles - metabolism</subject><subject>Health aspects</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Lipid membranes</subject><subject>Physiological aspects</subject><subject>Plasmids</subject><subject>Protein purification</subject><subject>Protein therapy</subject><subject>Protein Transport</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Research and Analysis Methods</subject><subject>Tat protein</subject><subject>Tetraspanin 29 - metabolism</subject><subject>Therapeutic applications</subject><subject>Vesicles</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkltr2zAYhsXYWLts_2BshsHYLpLpYFvy1QjZqRAo7HQrZPlToiJbqWSH9d9Ppm6JRy-GLnR63lf6Dgi9JHhFGCcfrvwQOuVWB9_BCjOCsWCP0DmpGF2WFLPHJ-sz9CzGK4wLJsryKTpjVU4E5fQcbddZ6xtrLDTZ5lOV9WqXGR8yMMZqC12fHYLvwXZZA84eIdxkR6sy-NMHpcG5wamQHSFa7SA-R0-MchFeTPMC_fry-efm23J7-fVis94udV7ifimoKLA2VECj85orwdK-rDVAqbHCOW84bxpOqTB1rpuKGKOgKrQuRFFzzNgCvb71PTgf5ZSIKBkhvKIYsyIRHydiqNv0TAokKCcPwbYq3EivrJzfdHYvd_4oCclFmbMyObybHIK_HiD2srVxjFh14IfpsYrlCV6gN_-gD39ponbKgbSd8WMKR1O5FoQWFafFGNrqASqNBlqrU6mNTeczwfuZIDF9qs5ODTHKix_f_5-9_D1n356we1Cu30fvht76Ls7B_BbUwccYwNxnmWA5dupdNuTYqXLq1CR7dVqhe9Fda7K_nEfjFA</recordid><startdate>20241017</startdate><enddate>20241017</enddate><creator>Inano, Shojiro</creator><creator>Kitano, Toshiyuki</creator><general>Public Library of Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0210-1158</orcidid></search><sort><creationdate>20241017</creationdate><title>A modified CD9 tag for efficient protein delivery via extracellular vesicles</title><author>Inano, Shojiro ; Kitano, Toshiyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-82850cf28edc4b7a838506bcee6c0a047d77dd7228fb4cd91ffae95cc585b7033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies</topic><topic>Biology and Life Sciences</topic><topic>CD9 antigen</topic><topic>Chromatography</topic><topic>Dosage and administration</topic><topic>Electroporation</topic><topic>Endosomes - metabolism</topic><topic>Extracellular vesicles</topic><topic>Extracellular Vesicles - metabolism</topic><topic>Health aspects</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Lipid membranes</topic><topic>Physiological aspects</topic><topic>Plasmids</topic><topic>Protein purification</topic><topic>Protein therapy</topic><topic>Protein Transport</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Research and Analysis Methods</topic><topic>Tat protein</topic><topic>Tetraspanin 29 - metabolism</topic><topic>Therapeutic applications</topic><topic>Vesicles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Inano, Shojiro</creatorcontrib><creatorcontrib>Kitano, Toshiyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale in Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database (ProQuest)</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Agriculture & Environmental Science Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Inano, Shojiro</au><au>Kitano, Toshiyuki</au><au>Kim, Cheorl-Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A modified CD9 tag for efficient protein delivery via extracellular vesicles</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2024-10-17</date><risdate>2024</risdate><volume>19</volume><issue>10</issue><spage>e0310083</spage><pages>e0310083-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Extracellular vesicles (EVs) are attracting growing attention for therapeutic use and as diagnostic markers, particularly for cancer. Although therapies based on small interfering RNAs are under intensive research, other therapeutic molecules, especially proteins, have not been sufficiently investigated. One of the major method for loading proteins into EVs is electroporation; however, it damages membrane integrity and requires repeated purification, precluding clinical applications. Thus, natural and efficient protein transfer is a prerequisite for the clinical application of protein-based EV therapy. Another prerequisite is an efficient endosomal escape, as most EVs incorporated into receptor cells result in endosomal degradation. Therefore, we generated a short CD9 (sCD9)-INF/TAT tag for efficiently transfers fused proteins to the EV and enhances endosomal escape to address the abovementioned problems. Interestingly, protein transfer via EVs drastically improved when the EV producer and receptor cells were cocultured, strongly indicating bystander effects of cells producing therapeutic proteins fused with a sCD9-INF/TAT tag. This method can be applied to a wide range of therapeutic technologies, including cellular transplantation or viral therapy.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>39418272</pmid><doi>10.1371/journal.pone.0310083</doi><orcidid>https://orcid.org/0000-0003-0210-1158</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2024-10, Vol.19 (10), p.e0310083 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_3117920035 |
source | MEDLINE; Public Library of Science; Full-Text Journals in Chemistry (Open access); DOAJ Directory of Open Access Journals; Free E-Journal (出版社公開部分のみ); PubMed Central |
subjects | Antibodies Biology and Life Sciences CD9 antigen Chromatography Dosage and administration Electroporation Endosomes - metabolism Extracellular vesicles Extracellular Vesicles - metabolism Health aspects HEK293 Cells Humans Lipid membranes Physiological aspects Plasmids Protein purification Protein therapy Protein Transport Proteins Receptors Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - metabolism Research and Analysis Methods Tat protein Tetraspanin 29 - metabolism Therapeutic applications Vesicles |
title | A modified CD9 tag for efficient protein delivery via extracellular vesicles |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T06%3A26%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20modified%20CD9%20tag%20for%20efficient%20protein%20delivery%20via%20extracellular%20vesicles&rft.jtitle=PloS%20one&rft.au=Inano,%20Shojiro&rft.date=2024-10-17&rft.volume=19&rft.issue=10&rft.spage=e0310083&rft.pages=e0310083-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0310083&rft_dat=%3Cgale_plos_%3EA812597253%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3117920035&rft_id=info:pmid/39418272&rft_galeid=A812597253&rfr_iscdi=true |